Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cabaletta Bio Inc
(NQ:
CABA
)
11.26
-0.96 (-7.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Cabaletta Bio Inc
< Previous
1
2
3
Next >
Cabaletta Bio Announces Pricing of Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces Proposed Public Offering of Common Stock
May 17, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Myositis
May 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Inc. (NASDAQ: CABA) is a Stock Spotlight on 5/2
May 02, 2023
Via
Investor Brand Network
Cabaletta Bio Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the American Society of Gene and Cell Therapy 26th Annual Meeting
May 02, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201
May 01, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Investor Conference at NASDAQ
April 25, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 13, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Receives FDA Clearance of IND Application for CABA-201 for Treatment of Systemic Lupus Erythematosus
March 31, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
March 16, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the Cowen 43rd Annual Health Care Conference
February 28, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease
January 09, 2023
From
Autolus Therapeutics plc
Via
GlobeNewswire
Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces $35 Million Offering
December 08, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference
November 22, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update
November 10, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio Announces CABA-201, a Newly Designed CD19-Targeting CAR T Cell Therapy Engineered to Address a Broad Range of Autoimmune Diseases
October 11, 2022
From
Cabaletta Bio
Via
GlobeNewswire
Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy
October 06, 2022
From
Cabaletta Bio
Via
GlobeNewswire
NASDAQ:CABA Long Term Investor Alert: Investigation over Potential Wrongdoing at Cabaletta Bio, Inc.
June 17, 2022
San Diego, CA -- (SBWIRE) -- 06/17/2022 -- Certain directors of Cabaletta Bio, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
Deadline Today Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm
April 29, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Deadline Today Alert: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm
April 29, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Deadline Tomorrow Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Contact the Firm
April 28, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
CABALETTA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Cabaletta Bio, Inc. and Encourages Investors to Contact the Firm
April 27, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Bronstein, Gewirtz & Grossman, LLC Reminds Cabaletta Bio, Inc. (CABA) Investors of Class Action Deadline and Encourages Investors to Contact the Firm
April 25, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
CABA SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important April 29 Deadline in Securities Class Action - CABA
April 22, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA
April 15, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CABA
April 10, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CABA
March 30, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
CABA Stock Investigation: Robbins LLP Investigates Cabaletta Bio, Inc. (CABA) on Behalf of Shareholders
March 18, 2022
From
Robbins LLP
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.